Antiphospholipid syndrome (APS) is an autoimmune thrombogenic disorder characterized by the presence of persistent antiphospholipid antibodies (aPL) in addition to the presence of clinical manifestations, whether venous or arterial thrombosis or pregnancy morbidities [1]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.